It has been established that HOTAIR is involved in hepatic insulin resistance via inhibiting sirtuin 1 (SIRT1), a potential therapeutic target to combat insulin resistance and diabetes, and suppressing the/Akt/glycogen synthase kinase-3β (GSK-3β) pathway [55, 56]. Here, GSK3B is linked to diabetes mellitus.